Defining thresholds for abnormal premature progesterone levels during ovarian stimulation for assisted reproduction technologies.

OBJECTIVE To evaluate methodologies to establish abnormal progesterone (P) levels on the day of trigger for recommending freeze only cycles. DESIGN Threshold analysis and cost analysis. SETTING Private ART practice. PATIENT(S) Fresh autologous ART. INTERVENTIONS(S) None. MAIN OUTCOME MEASURE(S) Live birth. RESULT(S) Fourteen established statistical methodologies for generating clinical thresholds were evaluated. These methods were applied to 7,608 fresh ART transfer cycles to generate various P thresholds which ranged widely from 0.4 to 3.0 ng/mL. Lower thresholds ranged from 0.4 to 1 ng/mL and classified the majority of cycles as abnormal as well as required very large number needed to treat (NNT) to increase one live birth. Frozen embryo transfer was cost-effective when P was ≥1.5 ng/mL, with 12% of the population having an abnormal test result and an NNT of 13. Statistical and cost-effective thresholds clustered between 1.5 and 2.0 ng/mL. CONCLUSION(S) Statistically significant thresholds for P were demonstrated as low as 0.4 ng/mL but resulted in a very large NNT to increase one live birth. A clinical benefit to a freeze-only approach was demonstrated above P thresholds ranging from 1.5 to 2.0 ng/dL. At these thresholds, elevated P has a demonstrable and clinically significant negative effect and captures a smaller percentage of the patient population at higher risk for fresh transfer failure, thus making freeze-only a cost-effective option.

[1]  M. Hill,et al.  Is the effect of premature elevated progesterone augmented by human chorionic gonadotropin versus gonadotropin-releasing hormone agonist trigger? , 2016, Fertility and sterility.

[2]  M. Hill,et al.  Does a frozen embryo transfer ameliorate the effect of elevated progesterone seen in fresh transfer cycles? , 2016, Fertility and sterility.

[3]  Bei Xu,et al.  Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles. , 2012, Fertility and sterility.

[4]  N. Obuchowski,et al.  Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.

[5]  M. Hill,et al.  Are good patient and embryo characteristics protective against the negative effect of elevated progesterone level on the day of oocyte maturation? , 2015, Fertility and sterility.

[6]  K. Pau,et al.  Precision of progesterone measurements with the use of automated immunoassay analyzers and the impact on clinical decisions for in vitro fertilization. , 2014, Fertility and sterility.

[7]  S. Mumford,et al.  Cost and efficacy comparison of in vitro fertilization and tubal anastomosis for women after tubal ligation. , 2015, Fertility and Sterility.

[8]  O. Ishihara,et al.  The economic impact of assisted reproductive technology: a review of selected developed countries. , 2009, Fertility and sterility.

[9]  D. Kissin,et al.  Costs of achieving live birth from assisted reproductive technology: a comparison of sequential single and double embryo transfer approaches. , 2015, Fertility and sterility.

[10]  R. Fanchin,et al.  Premature progesterone elevation spares blastulation but not pregnancy rates in in vitro fertilization with coculture. , 1997, Fertility and sterility.

[11]  Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. , 1984 .

[12]  M. Ohno,et al.  Cost-effectiveness analysis of preimplantation genetic screening and in vitro fertilization versus expectant management in patients with unexplained recurrent pregnancy loss. , 2014, Fertility and sterility.

[13]  M. Hill,et al.  Revisiting the progesterone to oocyte ratio. , 2017, Fertility and sterility.

[14]  K. Elkind-Hirsch,et al.  The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated basal follicle-stimulating hormone. , 2008, Fertility and sterility.

[15]  C. Simón,et al.  Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. , 2010, Human reproduction.

[16]  M. Hill,et al.  Does elevated progesterone on day of oocyte maturation play a role in the racial disparities in IVF outcomes? , 2017, Reproductive biomedicine online.

[17]  C. Venetis,et al.  Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles. , 2013, Human reproduction update.

[18]  M. Hill,et al.  The simplified SART embryo scoring system is highly correlated to implantation and live birth in single blastocyst transfers , 2012, Journal of Assisted Reproduction and Genetics.

[19]  A. Trounson,et al.  Changes in plasma progesterone concentrations around the time of the luteinizing hormone surge in women superovulated for in vitro fertilization. , 1984, The Journal of clinical endocrinology and metabolism.